日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Saccharophagus degradans UPF0434 protein Sde_1297 (Sde_1297) CSB-YP632474SAAX
CSB-EP632474SAAX
CSB-BP632474SAAX
CSB-MP632474SAAX
CSB-EP632474SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Enolase (eno) CSB-YP632475SAAX
CSB-EP632475SAAX
CSB-BP632475SAAX
CSB-MP632475SAAX
CSB-EP632475SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Peptide methionine sulfoxide reductase MsrB (msrB) CSB-YP632476SAAX
CSB-EP632476SAAX
CSB-BP632476SAAX
CSB-MP632476SAAX
CSB-EP632476SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Aspartate 1-decarboxylase (panD) CSB-YP632477SAAX
CSB-EP632477SAAX
CSB-BP632477SAAX
CSB-MP632477SAAX
CSB-EP632477SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Glucokinase (glk) CSB-YP632478SAAX
CSB-EP632478SAAX
CSB-BP632478SAAX
CSB-MP632478SAAX
CSB-EP632478SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Glucose-1-phosphate adenylyltransferase (glgC) CSB-YP632479SAAX
CSB-EP632479SAAX
CSB-BP632479SAAX
CSB-MP632479SAAX
CSB-EP632479SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans 50S ribosomal protein L15 (rplO) CSB-YP632480SAAX
CSB-EP632480SAAX
CSB-BP632480SAAX
CSB-MP632480SAAX
CSB-EP632480SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans 30S ribosomal protein S17 (rpsQ) CSB-YP632481SAAX
CSB-EP632481SAAX
CSB-BP632481SAAX
CSB-MP632481SAAX
CSB-EP632481SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans 30S ribosomal protein S10 (rpsJ) CSB-YP632482SAAX
CSB-EP632482SAAX
CSB-BP632482SAAX
CSB-MP632482SAAX
CSB-EP632482SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans 50S ribosomal protein L7/L12 (rplL) CSB-YP632483SAAX
CSB-EP632483SAAX
CSB-BP632483SAAX
CSB-MP632483SAAX
CSB-EP632483SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans UPF0761 membrane protein Sde_0901 (Sde_0901), partial CSB-YP632484SAAX1
CSB-EP632484SAAX1
CSB-BP632484SAAX1
CSB-MP632484SAAX1
CSB-EP632484SAAX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans D-alanine--D-alanine ligase (ddl) CSB-YP632485SAAX
CSB-EP632485SAAX
CSB-BP632485SAAX
CSB-MP632485SAAX
CSB-EP632485SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP632486SAAX
CSB-EP632486SAAX
CSB-BP632486SAAX
CSB-MP632486SAAX
CSB-EP632486SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Anthranilate phosphoribosyltransferase (trpD) CSB-YP632487SAAX
CSB-EP632487SAAX
CSB-BP632487SAAX
CSB-MP632487SAAX
CSB-EP632487SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP632488SAAX
CSB-EP632488SAAX
CSB-BP632488SAAX
CSB-MP632488SAAX
CSB-EP632488SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP632489SAAX
CSB-EP632489SAAX
CSB-BP632489SAAX
CSB-MP632489SAAX
CSB-EP632489SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Phosphomethylpyrimidine synthase (thiC), partial CSB-YP632490SAAX
CSB-EP632490SAAX
CSB-BP632490SAAX
CSB-MP632490SAAX
CSB-EP632490SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans UPF0391 membrane protein Sde_0270 (Sde_0270), partial CSB-YP632491SAAX
CSB-EP632491SAAX
CSB-BP632491SAAX
CSB-MP632491SAAX
CSB-EP632491SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Urease accessory protein UreD (ureD) CSB-YP632492SAAX
CSB-EP632492SAAX
CSB-BP632492SAAX
CSB-MP632492SAAX
CSB-EP632492SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharophagus degradans Glycine--tRNA ligase alpha subunit (glyQ) CSB-YP632493SAAX
CSB-EP632493SAAX
CSB-BP632493SAAX
CSB-MP632493SAAX
CSB-EP632493SAAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×